Home > Cashflow Statement > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS
Cashflow Statement

SHUKRA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SHUKRA PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹13 Cr₹20 Cr₹4.44 Cr₹1.02 Cr₹0.10 Cr
Adjustment ₹2.12 Cr₹1.55 Cr₹1.60 Cr₹1.91 Cr₹1.44 Cr
Changes In working Capital ₹-3.78 Cr₹-26 Cr₹-2.62 Cr₹5.50 Cr₹-1.00 Cr
Cash Flow after changes in Working Capital ₹12 Cr₹-4.57 Cr₹3.42 Cr₹8.43 Cr₹0.54 Cr
Cash Flow from Operating Activities ₹7.92 Cr₹-5.20 Cr₹3.17 Cr₹7.99 Cr₹0.54 Cr
Cash Flow from Investing Activities ₹-1.26 Cr₹-1.20 Cr₹-4.43 Cr₹-1.53 Cr₹-1.89 Cr
Cash Flow from Financing Activities ₹-4.52 Cr₹12 Cr₹4.94 Cr₹-6.68 Cr₹1.74 Cr
Net Cash Inflow / Outflow ₹2.14 Cr₹6.01 Cr₹3.68 Cr₹-0.21 Cr₹0.38 Cr
Opening Cash & Cash Equivalents ₹9.98 Cr₹3.97 Cr₹0.29 Cr₹0.50 Cr₹0.13 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹12 Cr₹9.98 Cr₹3.97 Cr₹0.29 Cr₹0.50 Cr

Compare Cashflow Statement of peers of SHUKRA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS ₹1,738.0 Cr -2.7% -10.7% 69.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


SHUKRA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS

-2.7%

-10.7%

69.6%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses